Last reviewed · How we verify
Evaluation of Steroidal Treatment For Dry Eye Disease
Many patients refer to an oculoplastic or corneal clinic examination due to dry eye symptoms. epidemiologic studies estimate that as many as 15% of the population over 60 years suffer from dry eye. the disease can be treated both topically through several drugs or through mechanical closure of the lacrimal drainage system. in the past decade a few studies demonstrated the efficacy of anti inflammatory treatment on dry eye disease due to the inflammatory process that occurs in it. this treatment rises goblet cell counts but in the meantime elevates the intra ocular pressure and elevates the risk for infections. steroids that cause a lower increase in intraocular pressure have not been thoroughly evaluated in dry eye disease. we with to subjectively and objectively evaluate an FDA approved topical steroidal drug in the treatment of dry eye.
Details
| Lead sponsor | Meir Medical Center |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | 2014-09 |
| Completion | 2015-09 |
Conditions
- Dry Eye
Interventions
- Loteprednol Etabonate (FML)
Primary outcomes
- clinical improvement in dry eye measurements — two months
tear break up time and schirmer 1 test will evaluate improvement in dry eye under medical treatment
Countries
Israel